Risk Evaluation and Mitigation Strategies (REMS) Compliance Program

  Рет қаралды 14,298

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
A Glance at Drug Importation Requirements
1:03:12
U.S. Food and Drug Administration
Рет қаралды 4,9 М.
Benefit-Risk Considerations During Drug Product Development (8of14) REdI 2018
40:26
U.S. Food and Drug Administration
Рет қаралды 5 М.
Арыстанның айқасы, Тәуіржанның шайқасы!
25:51
QosLike / ҚосЛайк / Косылайық
Рет қаралды 700 М.
Каха и дочка
00:28
К-Media
Рет қаралды 3,4 МЛН
Advancing Transparency and Regulatory Science Activities on Risk Evaluation and Mitigation Strategy
48:50
Division of Risk Management: Overview of Review Activities and REMS - Pharmacovigilance 2020
41:06
U.S. Food and Drug Administration
Рет қаралды 3,7 М.
REMS Integration Initiatives - Pharmacovigilance 2020
37:41
U.S. Food and Drug Administration
Рет қаралды 2,4 М.
Development of Shared System REMS & Implications of the Appropriations Act - Pharmacovigilance 2020
42:22
REMS Purpose, Process, and Challenges (1of2) REMS Webinar - Jun. 15, 2017
43:53
U.S. Food and Drug Administration
Рет қаралды 3,6 М.
Considerations for REMS Surveys and Assessments: Planning and Reporting - Pharmacovigilance 2020
38:16
Risk Basics for Medical Devices
23:18
U.S. Food and Drug Administration
Рет қаралды 10 М.
Update on Shared System REMS for Generic Drugs
15:11
U.S. Food and Drug Administration
Рет қаралды 717
REMS (February 2015)
4:19
U.S. Food and Drug Administration
Рет қаралды 11 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session Two
1:42:25
U.S. Food and Drug Administration
Рет қаралды 686
Арыстанның айқасы, Тәуіржанның шайқасы!
25:51
QosLike / ҚосЛайк / Косылайық
Рет қаралды 700 М.